The DOI matches its Crossref record; 140 of the 140 references it cites were found in a registry or an index.
Metabolic adaptation in hypoxia and cancer
Open accessAbstract
The ability of tumor cells to adapt to changes in oxygen tension is essential for tumor development. Low oxygen concentration influences cellular metabolism and, thus, affects proliferation, migration, and invasion. A focal point of the cell’s adaptation to hypoxia is the transcription factor HIF1α (hypoxia-inducible factor 1 alpha), which affects the expression of specific gene networks involved in cellular energetics and metabolism. This review illustrates the mechanisms by which HIF1α-induced metabolic adaptation promotes angiogenesis, participates in the escape from immune recognition, and increases cancer cell antioxidant capacity. In addition to hypoxia, metabolic inhibition of 2-oxoglutarate-dependent dioxygenases regulates HIF1α stability and transcriptional activity. This phenomenon, known as pseudohypoxia, is frequently used by cancer cells to promote glycolytic metabolism to support biomass synthesis for cell growth and proliferation. In this review, we highlight the role of the most important metabolic intermediaries that are at the center of cancer’s biology, and in particular, the participation of these metabolites in HIF1α retrograde signaling during the establishment of pseudohypoxia. Finally, we will discuss how these changes affect both the development of cancers and their resistance to treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Peng, M., Yang, D., Hou, Y., Liu, S., Zhao, M., Qin, Y., Chen, R., Teng, Y., & Liu, M. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1475-7 · Cited by 100
RetractedWarburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425
Metabolic regulation of gene expression by histone lactylation
Zhang, D., Tang, Z., Huang, H., Zhou, G., Cui, C., Weng, Y., Liu, W., Kim, S., Lee, S., Perez-Neut, M., et al. (2019) · Nature · doi:10.1038/s41586-019-1678-1 · Cited by 4,371
Cancer-associated IDH1 mutations produce 2-hydroxyglutarate
Dang, L., White, D. W., Gross, S., Bennett, B. D., Bittinger, M. A., Driggers, E. M., Fantin, V. R., Jang, H. G., Jin, S., Keenan, M. C., et al. (2009) · Nature · doi:10.1038/nature08617 · Cited by 4,154
Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1
Forsythe, J. A., Jiang, B.-H., Iyer, N. V., Agani, F., Leung, S. W., Koos, R. D., & Semenza, G. L. (1996) · Molecular and Cellular Biology · doi:10.1128/mcb.16.9.4604 · Cited by 3,981 · cited 5×
“A uthor M anuscript A uthor M anuscript A uthor M anuscript A uthor M anuscript Lactate Angiogenesis Cell migration VEGF production HIF1α stabilization Avoidance of the Immune System Treatment resistance Adeva-Andany, et al. Mitocondrion, 2014 Vegran, et al. Cancer Res, 2011 Beckert, et al. 2006 Baltazar, et al. J Imm…”
BackgroundInfluentialDeBerardinis, R. J., Mancuso, A., Daikhin, E., Nissim, I., Yudkoff, M., Wehrli, S., & Thompson, C. B. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709747104 · Cited by 2,622
HIF-1 mediates adaptation to hypoxia by actively downregulating mitochondrial oxygen consumption
Papandreou, I., Cairns, R. A., Fontana, L., Lim, A. L., & Denko, N. C. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.012 · Cited by 2,267
Ward, P. S., Patel, J., Wise, D. R., Abdel-Wahab, O., Bennett, B. D., Coller, H. A., Cross, J. R., Fantin, V. R., Hedvat, C. V., Perl, A. E., et al. (2010) · Cancer Cell · doi:10.1016/j.ccr.2010.01.020 · Cited by 2,020
Inhibitory effect of tumor cell-derived lactic acid on human T cells
Fischer, K., Hoffmann, P., Voelkl, S., Meidenbauer, N., Ammer, J., Edinger, M., Gottfried, E., Schwarz, S., Rothe, G., Hoves, S., et al. (2007) · Blood · doi:10.1182/blood-2006-07-035972 · Cited by 1,946
Lando, D., Peet, D. J., Gorman, J. J., Whelan, D. A., Whitelaw, M. L., & Bruick, R. K. (2002) · Genes & Development · doi:10.1101/gad.991402 · Cited by 1,550 · cited 1×
“By hydroxylation of asparagine 803 within the CAD, the association of HIF1α with its coactivators is impeded, thereby reducing HIF1α activity [10].”
BackgroundEnasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia
Stein, E. M., DiNardo, C. D., Pollyea, D. A., Fathi, A. T., Roboz, G. J., Altman, J. K., Stone, R. M., DeAngelo, D. J., Levine, R. L., Flinn, I. W., et al. (2017) · Blood · doi:10.1182/blood-2017-04-779405 · Cited by 1,516
General involvement of hypoxia-inducible factor 1 in transcriptional response to hypoxia.
Wang, G. L., & Semenza, G. L. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.9.4304 · Cited by 1,468
Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1
Luo, W., Hu, H., Chang, R., Zhong, J., Knabel, M., O'Meally, R., Cole, R. N., Pandey, A., & Semenza, G. L. (2011) · Cell · doi:10.1016/j.cell.2011.03.054 · Cited by 1,463
Xiao, M., Yang, H., Xu, W., Ma, S., Lin, H., Zhu, H., Liu, L., Liu, Y., Yang, C., Xu, Y., et al. (2012) · Genes & Development · doi:10.1101/gad.191056.112 · Cited by 1,188 · cited 1×
“Elevated levels of succinate caused by SDH loss-of-function are associated with impaired JmjC and TET activity, leading to dysregulation of proliferation and migration genes [72], loss of the Electron transport chain complex II [15, 73], and increased ROS production [69].”
BackgroundThe key role of anaplerosis and cataplerosis for citric acid cycle function
Owen, O. E., Kalhan, S. C., & Hanson, R. W. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200006200 · Cited by 1,172 · cited 1×
“Pyruvate, through anaplerotic reactions, may contribute carbon to these synthetic activities [101].”
BackgroundHartmann, C., Meyer, J., Balss, J., Capper, D., Mueller, W., Christians, A., Felsberg, J., Wolter, M., Mawrin, C., Wick, W., et al. (2009) · Acta Neuropathologica · doi:10.1007/s00401-009-0561-9 · Cited by 1,163
Lactate: A Metabolic Key Player in Cancer
Hirschhaeuser, F., Sattler, U. G. A., & Mueller-Klieser, W. (2011) · Cancer Research · doi:10.1158/0008-5472.can-11-1457 · Cited by 1,090
NAD(H) and NADP(H) Redox Couples and Cellular Energy Metabolism
Xiao, W., Wang, R.-S., Handy, D. E., & Loscalzo, J. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7216 · Cited by 1,061
Analysis of the IDH1 codon 132 mutation in brain tumors
Balss, J., Meyer, J., Mueller, W., Korshunov, A., Hartmann, C., & von Deimling, A. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0455-2 · Cited by 1,036
The oncometabolite 2-hydroxyglutarate inhibits histone lysine demethylases
Chowdhury, R., Yeoh, K. K., Tian, Y., Hillringhaus, L., Bagg, E. A., Rose, N. R., Leung, I. K. H., Li, X. S., Woon, E. C. Y., Yang, M., et al. (2011) · The EMBO Reports · doi:10.1038/embor.2011.43 · Cited by 1,035 · cited 11×
“Like PHDs, in addition to oxygen, FIH uses α-KG as a substrate and requires Fe2+ and ascorbate as cofactors [11] (Figure 1).”
BackgroundInfluentialGao, X., Wu, G., Gu, X., Fu, L., & Mei, C. (2013) · Kidney and Blood Pressure Research · doi:10.1159/000355743 · Cited by 1,035
Identification of lysine succinylation as a new post-translational modification
Zhang, Z., Tan, M., Xie, Z., Dai, L., Chen, Y., & Zhao, Y. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.495 · Cited by 1,027
Amary, M. F., Bacsi, K., Maggiani, F., Damato, S., Halai, D., Berisha, F., Pollock, R., O'Donnell, P., Grigoriadis, A., Diss, T., et al. (2011) · The Journal of Pathology · doi:10.1002/path.2913 · Cited by 1,023
Wise, D. R., Ward, P. S., Shay, J. E. S., Cross, J. R., Gruber, J. J., Sachdeva, U. M., Platt, J. M., DeMatteo, R. G., Simon, M. C., & Thompson, C. B. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1117773108 · Cited by 975
Isaacs, J. S., Jung, Y. J., Mole, D. R., Lee, S., Torres-Cabala, C., Chung, Y.-L., Merino, M., Trepel, J., Zbar, B., Toro, J., et al. (2005) · Cancer Cell · doi:10.1016/j.ccr.2005.06.017 · Cited by 958 · cited 2×
“Fumarate competitively inhibits 2OGDDs, leading to HIF1α stabilization and pseudohypoxia, which is associated with tumor growth and metastasis [90].”
BackgroundLactate in the Regulation of Tumor Microenvironment and Therapeutic Approaches
de la Cruz-López, K. G., Castro-Muñoz, L. J., Reyes-Hernández, D. O., García-Carrancá, A., & Manzo-Merino, J. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.01143 · Cited by 940 · cited 4×
“In these cancers, where aerobic glycolysis persists, the excess lactate excreted by tumors creates an acidic environment that contributes to metastasis and angiogenesis [130].”
BackgroundInfluentialPollard, P. J., Brière, J. J., Alam, N. A., Barwell, J., Barclay, E., Wortham, N. C., Hunt, T., Mitchell, M., Olpin, S., Moat, S. J., et al. (2005) · Human Molecular Genetics · doi:10.1093/hmg/ddi227 · Cited by 865
Lu, H., Forbes, R. A., & Verma, A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202487200 · Cited by 837
Husain, Z., Huang, Y., Seth, P., & Sukhatme, V. P. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1202702 · Cited by 822
Végran, F., Boidot, R., Michiels, C., Sonveaux, P., & Feron, O. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2828 · Cited by 816
Characterization of the human prolyl 4-hydroxylases that modify the hypoxia-inducible factor
Hirsilä, M., Koivunen, P., Günzler, V., Kivirikko, K. I., & Myllyharju, J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304982200 · Cited by 794
Transcriptional regulation by hypoxia inducible factors
Dengler, V. L., Galbraith, M. D., & Espinosa, J. M. (2014) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.838205 · Cited by 782
Weinert, B. T., Schölz, C., Wagner, S. A., Iesmantavicius, V., Su, D., Daniel, J. A., & Choudhary, C. (2013) · Cell Reports · doi:10.1016/j.celrep.2013.07.024 · Cited by 753
Borger, D. R., Tanabe, K. K., Fan, K. C., Lopez, H. U., Fantin, V. R., Straley, K. S., Schenkein, D. P., Hezel, A. F., Ancukiewicz, M., Liebman, H. M., et al. (2012) · The Oncologist · doi:10.1634/theoncologist.2011-0386 · Cited by 728
Hypoxia and Metabolic Adaptation of Cancer Cells
Eales, K. L., Hollinshead, K. E. R., & Tennant, D. A. (2016) · Oncogenesis · doi:10.1038/oncsis.2015.50 · Cited by 724 · cited 1×
“Under hypoxia or pseudohypoxia, a concomitant increase in HIF1α activity upregulates PDK1 and lactate dehydrogenase A, further diverting pyruvate metabolism towards lactate formation [126, 127].”
BackgroundMetabolic Modulation of Glioblastoma with Dichloroacetate
Michelakis, E. D., Sutendra, G., Dromparis, P., Webster, L., Haromy, A., Niven, E., Maguire, C., Gammer, T.-L., Mackey, J. R., Fulton, D., et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3000677 · Cited by 720
Dichloroacetate (DCA) as a potential metabolic-targeting therapy for cancer
Michelakis, E. D., Webster, L., & Mackey, J. R. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604554 · Cited by 656
Sutendra, G., Kinnaird, A., Dromparis, P., Paulin, R., Stenson, T. H., Haromy, A., Hashimoto, K., Zhang, N., Flaim, E., & Michelakis, E. D. (2014) · Cell · doi:10.1016/j.cell.2014.04.046 · Cited by 648
Comprehensive review on lactate metabolism in human health
Adeva-Andany, M., López-Ojén, M., Funcasta-Calderón, R., Ameneiros-Rodríguez, E., Donapetry-García, C., Vila-Altesor, M., & Rodríguez-Seijas, J. (2014) · Mitochondrion · doi:10.1016/j.mito.2014.05.007 · Cited by 615
Williams, N. C., & O’Neill, L. A. J. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00141 · Cited by 570
Succinate, an intermediate in metabolism, signal transduction, ROS, hypoxia, and tumorigenesis
Tretter, L., Patocs, A., & Chinopoulos, C. (2016) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2016.03.012 · Cited by 539
Wu, J.-Y., Huang, T.-W., Hsieh, Y.-T., Wang, Y.-F., Yen, C.-C., Lee, G.-L., Yeh, C.-C., Peng, Y.-J., Kuo, Y.-Y., Wen, H.-T., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2019.10.023 · Cited by 535
Pyruvate carboxylase is critical for non–small-cell lung cancer proliferation
Sellers, K., Fox, M. P., Bousamra, M., Slone, S. P., Higashi, R. M., Miller, D. M., Wang, Y., Yan, J., Yuneva, M. O., Deshpande, R., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci72873 · Cited by 497
2-Oxoglutarate-Dependent Oxygenases
Islam, M. S., Leissing, T. M., Chowdhury, R., Hopkinson, R. J., & Schofield, C. J. (2018) · Annual Review of Biochemistry · doi:10.1146/annurev-biochem-061516-044724 · Cited by 472
Succinate dehydrogenase – Assembly, regulation and role in human disease
Rutter, J., Winge, D. R., & Schiffman, J. D. (2010) · Mitochondrion · doi:10.1016/j.mito.2010.03.001 · Cited by 462
Mitochondrial complex I activity and NAD+/NADH balance regulate breast cancer progression
Santidrian, A. F., Matsuno-Yagi, A., Ritland, M., Seo, B. B., LeBoeuf, S. E., Gay, L. J., Yagi, T., & Felding-Habermann, B. (2013) · Journal of Clinical Investigation · doi:10.1172/jci64264 · Cited by 433
Lactate: mirror and motor of tumor malignancy
Walenta, S., & Mueller-Klieser, W. F. (2004) · Seminars in Radiation Oncology · doi:10.1016/j.semradonc.2004.04.004 · Cited by 428
Oncometabolites: linking altered metabolism with cancer
Yang, M., Soga, T., & Pollard, P. J. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67228 · Cited by 422
ATP citrate lyase: activation and therapeutic implications in non-small cell lung cancer
Migita, T., Narita, T., Nomura, K., Miyagi, E., Inazuka, F., Matsuura, M., Ushijima, M., Mashima, T., Seimiya, H., Satoh, Y., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1235 · Cited by 403
Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Fodstad, O., Riker, A. I., Kamarajugadda, S., Lu, J., Owen, L. B., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-33 · Cited by 395
Li, L., Shi, L., Yang, S., Yan, R., Zhang, D., Yang, J., He, L., Li, W., Yi, X., Sun, L., et al. (2016) · Nature Communications · doi:10.1038/ncomms12235 · Cited by 391
Role of histone acetylation in the control of gene expression
Verdone, L., Caserta, M., & Mauro, E. D. (2005) · Biochemistry and Cell Biology · doi:10.1139/o05-041 · Cited by 388
Pyruvate Dehydrogenase Complex Activity Controls Metabolic and Malignant Phenotype in Cancer Cells
McFate, T., Mohyeldin, A., Lu, H., Thakar, J., Henriques, J., Halim, N. D., Wu, H., Schell, M. J., Tsang, T. M., Teahan, O., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m801765200 · Cited by 385
Oldham, W. M., Clish, C. B., Yang, Y., & Loscalzo, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.06.021 · Cited by 364 · cited 1×
“The D-2-HG enantiomer, L-2-HG, was recently identified as an abnormal α-KG metabolism product under hypoxia [63].”
BackgroundReductive glutamine metabolism is a function of the α-ketoglutarate to citrate ratio in cells
Fendt, S.-M., Bell, E. L., Keibler, M. A., Olenchock, B. A., Mayers, J. R., Wasylenko, T. M., Vokes, N. I., Guarente, L., Heiden, M. G. V., & Stephanopoulos, G. (2013) · Nature Communications · doi:10.1038/ncomms3236 · Cited by 364 · cited 1×
“Under hypoxia and pseudohypoxia, α-KG is generated in anaplerotic reactions, and α-KGDH activity is reduced [1, 44].”
BackgroundMacKenzie, E. D., Selak, M. A., Tennant, D. A., Payne, L. J., Crosby, S., Frederiksen, C. M., Watson, D. G., & Gottlieb, E. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01927-06 · Cited by 359
Apicella, M., Giannoni, E., Fiore, S., Ferrari, K. J., Fernández-Pérez, D., Isella, C., Granchi, C., Minutolo, F., Sottile, A., Comoglio, P. M., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.08.006 · Cited by 299
Tumor-Secreted Lactic Acid Promotes IL-23/IL-17 Proinflammatory Pathway
Shime, H., Yabu, M., Akazawa, T., Kodama, K., Matsumoto, M., Seya, T., & Inoue, N. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.11.7175 · Cited by 285
Citrate – new functions for an old metabolite
Iacobazzi, V., & Infantino, V. (2014) · Biological Chemistry · doi:10.1515/hsz-2013-0271 · Cited by 285
l -2-Hydroxyglutarate: An Epigenetic Modifier and Putative Oncometabolite in Renal Cancer
Shim, E.-H., Livi, C. B., Rakheja, D., Tan, J., Benson, D., Parekh, V., Kho, E.-Y., Ghosh, A. P., Kirkman, R., Velu, S., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0696 · Cited by 280
Secretion of pyruvate. An antioxidant defense of mammalian cells.
O'Donnell-Tormey, J., Nathan, C. F., Lanks, K., DeBoer, C. J., & de la Harpe, J. (1987) · The Journal of experimental medicine · doi:10.1084/jem.165.2.500 · Cited by 280
Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma
Yahagi, N., Shimano, H., Hasegawa, K., Ohashi, K., Matsuzaka, T., Najima, Y., Sekiya, M., Tomita, S., Okazaki, H., Tamura, Y., et al. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2004.12.037 · Cited by 248
Granchi, C. (2018) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2018.09.001 · Cited by 245
Identification of small molecule inhibitors of pyruvate kinase M2
Vander Heiden, M. G., Christofk, H. R., Schuman, E., Subtelny, A. O., Sharfi, H., Harlow, E. E., Xian, J., & Cantley, L. C. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.12.003 · Cited by 237
Non-Canonical Mechanisms Regulating Hypoxia-Inducible Factor 1 Alpha in Cancer
Iommarini, L., Porcelli, A. M., Gasparre, G., & Kurelac, I. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00286 · Cited by 231
Increased risk of cancer in patients with fumarate hydratase germline mutation
Lehtonen, H. J., Kiuru, M., Ylisaukko-oja, S. K., Salovaara, R., Herva, R., Koivisto, P. A., Vierimaa, O., Aittomäki, K., Pukkala, E., Launonen, V, et al. (2006) · Journal of Medical Genetics · doi:10.1136/jmg.2005.036400 · Cited by 225
Zdzisińska, B., Żurek, A., & Kandefer-Szerszeń, M. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-016-0406-x · Cited by 221
Yogev, O., Yogev, O., Singer, E., Shaulian, E., Goldberg, M., Fox, T. D., & Pines, O. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000328 · Cited by 220 · cited 1×
“In the cytosol, FH participates in multiple pathways, such as the urea and the purine nucleotide cycles [88].”
BackgroundKoukourakis, M. I., Giatromanolaki, A., Sivridis, E., Gatter, K. C., & Harris, A. L. (2005) · Neoplasia · doi:10.1593/neo.04373 · Cited by 214
Glycolytic metabolism and tumour response to fractionated irradiation
Sattler, U. G. A., Meyer, S. S., Quennet, V., Hoerner, C., Knoerzer, H., Fabian, C., Yaromina, A., Zips, D., Walenta, S., Baumann, M., et al. (2010) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2009.11.007 · Cited by 212
Anaplerotic molecules: Current and future
Brunengraber, H., & Roe, C. R. (2006) · Journal of Inherited Metabolic Disease · doi:10.1007/s10545-006-0320-1 · Cited by 202
Intermediates of Metabolism: From Bystanders to Signalling Molecules
Haas, R., Cucchi, D., Smith, J., Pucino, V., Macdougall, C. E., & Mauro, C. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2016.02.003 · Cited by 193
The emerging role of fumarate as an oncometabolite
Yang, M., Soga, T., Pollard, P. J., & Adam, J. (2012) · Frontiers in Oncology · doi:10.3389/fonc.2012.00085 · Cited by 189
Lactate stimulates endothelial cell migration
Beckert, S., Farrahi, F., Aslam, R. S., Scheuenstuhl, H., Königsrainer, A., Hussain, M. Z., & Hunt, T. K. (2006) · Wound Repair and Regeneration · doi:10.1111/j.1743-6109.2006.00127.x · Cited by 187
An Overview of Phenylalanine and Tyrosine Kinetics in Humans
Matthews, D. E. (2007) · The Journal of Nutrition · doi:10.1093/jn/137.6.1549s · Cited by 183
Stuart, S. D., Schauble, A., Gupta, S., Kennedy, A. D., Keppler, B. R., Bingham, P. M., & Zachar, Z. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-4 · Cited by 183
Protein Hydroxylation Catalyzed by 2-Oxoglutarate-dependent Oxygenases
Markolovic, S., Wilkins, S. E., & Schofield, C. J. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.662627 · Cited by 181
Pollard, P. J., Spencer-Dene, B., Shukla, D., Howarth, K., Nye, E., El-Bahrawy, M., Deheragoda, M., Joannou, M., McDonald, S., Martin, A., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.02.005 · Cited by 178
Smestad, J. A., Erber, L. N., Chen, Y., & Maher, L. J. (2018) · iScience · doi:10.1016/j.isci.2018.03.012 · Cited by 178
Targets of gene amplification and overexpression at 17q in gastric cancer.
Varis, A., Wolf, M., Monni, O. M., Vakkari, M.-L., Kokkola, A., Moskaluk, C., Frierson, H. F., Powell, S. M., Knuutila, S., Kallioniemi, A. H., et al. (2002) · PubMed · Cited by 177
Lactate Beyond a Waste Metabolite: Metabolic Affairs and Signaling in Malignancy
Baltazar, F., Afonso, J., Costa, M. F., & Granja, S. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00231 · Cited by 174
Lin, C.-C., Cheng, T., Tsai, W., Tsai, H.-J., Hu, K.-H., Chang, H., Yeh, C., Chen, Y.-C., Liao, C.-C., & Chang, W. (2012) · Scientific Reports · doi:10.1038/srep00785 · Cited by 172
The expanded role of fatty acid metabolism in cancer: new aspects and targets
Chen, M., & Huang, J. (2019) · Precision Clinical Medicine · doi:10.1093/pcmedi/pbz017 · Cited by 169
Desai, S., Ding, M., Wang, B., Lu, Z., Zhao, Q., Shaw, K., Yung, W. K. A., Weinstein, J. N., Tan, M., & Yao, J. (2014) · Oncotarget · doi:10.18632/oncotarget.1159 · Cited by 167
The redox requirements of proliferating mammalian cells
Hosios, A. M., & Heiden, M. G. V. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.tm117.000239 · Cited by 158
Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes
Wong, B. W., Kuchnio, A., Brüning, U., & Carmeliet, P. (2012) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2012.10.004 · Cited by 157
Desquiret‐Dumas, V., Guéguen, N., Leman, G., Baron, S., Nivet‐Antoine, V., Chupin, S., Chevrollier, A., Vessières, E., Ayer, A., Ferré, M., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.466490 · Cited by 150
‘Why do tumour cells glycolyse?’: From glycolysis through citrate to lipogenesis
Costello, L. C., & FRANKLIN, R. B. (2005) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-005-8841-8 · Cited by 150
Anaplerotic roles of pyruvate carboxylase in mammalian tissues
Jitrapakdee, S., Vidal-Puig, A., & Wallace, J. C. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5410-y · Cited by 149
Acidic pH Is a Metabolic Switch for 2-Hydroxyglutarate Generation and Signaling
Nadtochiy, S. M., Schafer, X., Fu, D., Nehrke, K., Munger, J., & Brookes, P. S. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.738799 · Cited by 143
The Redox Status of Cancer Cells Supports Mechanisms behind the Warburg Effect
Moreira, J. D. V., Hamraz, M., Abolhassani, M., Bigan, E., Pérès, S., Paulevé, L., Nogueira, M. L., Steyaert, J., & Schwartz, L. H. (2016) · Metabolites · doi:10.3390/metabo6040033 · Cited by 143
The α-ketoglutarate dehydrogenase complex in cancer metabolic plasticity
Vatrinet, R., Leone, G., Luise, M. D., Girolimetti, G., Vidone, M., Gasparre, G., & Porcelli, A. M. (2017) · Cancer & Metabolism · doi:10.1186/s40170-017-0165-0 · Cited by 140
Ren, J.-G., Seth, P., Ye, H., Guo, K., Hanai, J., Husain, Z., & Sukhatme, V. P. (2017) · Scientific Reports · doi:10.1038/s41598-017-04626-4 · Cited by 140
CPT1A‐mediated succinylation of S100A10 increases human gastric cancer invasion
Wang, C., Zhang, C., Li, X., Shen, J., Xu, Y., Shi, H., Mu, X., Pan, J.-S., Zhao, T., Li, M., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13920 · Cited by 136
Murugan, A. K., Bojdani, E., & Xing, M. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.095 · Cited by 135
Diers, A. R., Broniowska, K. A., Chang, C.-F., & Hogg, N. (2012) · Biochemical Journal · doi:10.1042/bj20120294 · Cited by 133
Gao, H., Dong, B., Liu, X., Xuan, H., Huang, Y., & Lin, D. (2008) · Analytica Chimica Acta · doi:10.1016/j.aca.2008.06.051 · Cited by 132
Tseng, C.-W., Kuo, W., Chan, S., Chan, H., Chang, K., & Wang, L. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2906 · Cited by 131
Kim, E.-Y., Chung, T., Han, C. W., Park, M.-J., Park, K. H., Jang, S. B., & Ha, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40617-3 · Cited by 129
The mitochondrial citrate carrier: Metabolic role and regulation of its activity and expression
Gnoni, G. V., Priore, P., Geelen, M. J. H., & Siculella, L. (2009) · IUBMB Life · doi:10.1002/iub.249 · Cited by 117
Phannasil, P., Thuwajit, C., Warnnissorn, M., Wallace, J. C., MacDonald, M. J., & Jitrapakdee, S. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129848 · Cited by 116
Differentiation of human tumors from nonmalignant tissue by natural‐abundance 13C NMR spectroscopy
Halliday, K. R., Fenoglio‐Preiser, C., & Sillerud, L. O. (1988) · Magnetic Resonance in Medicine · doi:10.1002/mrm.1910070403 · Cited by 116
Urea biosynthesis I. The urea cycle and relationships to the citric acid cycle
Shambaugh, G. (1977) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/30.12.2083 · Cited by 116
Enhanced Citrate Synthase Activity in Human Pancreatic Cancer
Schlichtholz, B., Turyn, J., Goyke, E., Biernacki, M., Jaśkiewicz, K., Śledziński, Z., & Świerczyński, J. (2005) · Pancreas · doi:10.1097/01.mpa.0000153326.69816.7d · Cited by 111
Succinate Can Shuttle Reducing Power from the Hypoxic Retina to the O2-Rich Pigment Epithelium
Bisbach, C. M., Hass, D. T., Robbings, B. M., Rountree, A. M., Sadílek, M., Sweet, I. R., & Hurley, J. B. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107606 · Cited by 106
Qi, H., Ning, X., Yu, C., Ji, X., Jin, Y., McNutt, M. A., & Yin, Y. (2019) · Cell Death and Disease · doi:10.1038/s41419-018-1271-9 · Cited by 102
Metabolic regulation by lactate
Sola‐Penna, M. (2008) · IUBMB Life · doi:10.1002/iub.97 · Cited by 95
Citrate Synthase Expression Affects Tumor Phenotype and Drug Resistance in Human Ovarian Carcinoma
Chen, L., Liu, T., Zhou, J., Wang, Y., Wang, X., Di, W. J., & Zhang, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115708 · Cited by 93
Tarhonskaya, H., Hardy, A., Howe, E. A., Loik, N. D., Kramer, H., McCullagh, J., Schofield, C. J., & Flashman, E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.653014 · Cited by 92
Hlouschek, J., Hansel, C., Jendrossek, V., & Matschke, J. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00170 · Cited by 91
Icard, P., & Lincet, H. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.003 · Cited by 90
Lapachol inhibits glycolysis in cancer cells by targeting pyruvate kinase M2
Babu, M. S., Mahanta, S. K., Lakhter, A. J., Hato, T., Paul, S., & Naidu, S. R. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191419 · Cited by 90
α-ketoglutarate dehydrogenase inhibition counteracts breast cancer-associated lung metastasis
Atlante, S., Visintin, A., Marini, E., Savoia, M., Dianzani, C., Giorgis, M., Sürün, D., Maione, F., Schnütgen, F., Farsetti, A., et al. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0802-8 · Cited by 88
Integrated genomic study of quadruple-WT GIST (KIT/PDGFRA/SDH/RAS pathway wild-type GIST)
Nannini, M., Astolfi, A., Urbini, M., Indio, V., Santini, D., Heinrich, M. C., Corless, C. L., Ceccarelli, C., Saponara, M., Mandrioli, A., et al. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-685 · Cited by 87
Molecular cloning of the p45 subunit of pyruvate dehydrogenase kinase.
Popov, K. M., Kedishvili, N. Y., Zhao, Y., Gudi, R., & Harris, R. A. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)43940-3 · Cited by 84
Targeting Pyruvate Carboxylase by a Small Molecule Suppresses Breast Cancer Progression
Lin, Q., He, Y., Wang, X., Zhang, Y., Hu, M., Guo, W., He, Y., Zhang, T., Lai, L., Sun, Z., et al. (2020) · Advanced Science · doi:10.1002/advs.201903483 · Cited by 74
Yancy, H. F., Mason, J. A., Peters, S. M., Thompson, C. E., Littleton, G. K., Jett, M., & Day, A. A. (2007) · Journal of Carcinogenesis · doi:10.1186/1477-3163-6-8 · Cited by 68
Sun, J., Aluvila, S., Kotaria, R., Mayor, J. A., Walters, D. E., & Kaplan, R. S. (2010) · PubMed · Cited by 66
Wang, H., Chen, Y., & Wu, G. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.09.009 · Cited by 64
The effects of 2-hydroxyglutarate on the tumorigenesis of gliomas
Reiter–Brennan, C., Semmler, L., & Klein, A. (2018) · Współczesna Onkologia · doi:10.5114/wo.2018.82642 · Cited by 60
Targeting citrate as a novel therapeutic strategy in cancer treatment
Huang, L., Wang, C., Xu, H., & Peng, G. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.188332 · Cited by 60
Dichloroacetate and metformin synergistically suppress the growth of ovarian cancer cells
Li, B., Li, X., Ni, Z., Zhang, Y., Zeng, Y., Yan, X., Huang, Y., He, J., Lyu, X., Wu, Y., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.10694 · Cited by 57
Lu, X., Zhou, D., Hou, B., Liu, Q., Chen, Q., Deng, X., Yu, Z., Dai, J., & Zheng, H. (2018) · Cancer Management and Research · doi:10.2147/cmar.s156530 · Cited by 54
Considering the role of pyruvate in tumor cells during hypoxia
Roudier, E. A., & Perrin, A. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.02.003 · Cited by 52
Hypoxia and succinate antagonize 2-deoxyglucose effects on glioblastoma
Pistollato, F., Abbadi, S., Rampazzo, E., Viola, G., Puppa, A. D., Cavallini, L., Frasson, C., Persano, L., Panchision, D. M., & Basso, G. (2010) · Biochemical Pharmacology · doi:10.1016/j.bcp.2010.08.003 · Cited by 51 · cited 1×
“Likewise, the exogenous addition of succinate stabilizes HIF1α and increases the growth and proliferation of glioblastoma cells [71].”
BackgroundAntitumor effects of 2‐oxoglutarate through inhibition of angiogenesis in a murine tumor model
Matsumoto, K., Obara, N., Ema, M., Horie, M., Naka, A., Takahashi, S., & Imagawa, S. (2009) · Cancer Science · doi:10.1111/j.1349-7006.2009.01249.x · Cited by 48
Matsumoto, K., Imagawa, S., Obara, N., Suzuki, N., Takahashi, S., Nagasawa, T., & Yamamoto, M. P. (2006) · Journal of Cellular Physiology · doi:10.1002/jcp.20733 · Cited by 46
Kaplan, R. S., Morris, H. P., & Coleman, P. S. (1982) · PubMed · Cited by 43
Germline and somatic SDHx alterations in apparently sporadic differentiated thyroid cancer
Ni, Y., Seballos, S. S., Ganapathi, S. S., Gurin, D., Fletcher, B., Ngeow, J. Y. Y., Nagy, R. S., Kloos, R. T., Ringel, M. D., LaFramboise, T., et al. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0537 · Cited by 43
Saito, Y., Ishii, K., Aita, Y., Ikeda, T., Kawakami, Y., Shimano, H., Hara, H., & Takekoshi, K. (2015) · Neurochemical Research · doi:10.1007/s11064-015-1738-3 · Cited by 39
Lee, G. Y., Chun, Y., Shin, H., & Park, J. (2016) · Oncotarget · doi:10.18632/oncotarget.10684 · Cited by 36
The Regulatory Role of NAD in Human and Animal Cells
Kulikova, V., Gromyko, D. V., & Nikiforov, A. A. (2018) · Biochemistry (Moscow) · doi:10.1134/s0006297918070040 · Cited by 36
Down‐regulation of PKM 2 enhances anticancer efficiency of THP on bladder cancer
Su, Q., Tao, T., Tang, L., Deng, J., Darko, K. O., Zhou, S., Peng, M., He, S., Zeng, Q., Chen, A. F., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13571 · Cited by 31
In vitro cytotoxicity of combinations of dichloroacetate with anticancer platinum compounds
Hamilton (2010) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s11795 · Cited by 30
Sun, L., Moritake, T., Ito, K., Matsumoto, Y., Yasui, H., Nakagawa, H., Hirayama, A., Inanami, O., & Tsuboi, K. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176162 · Cited by 24
DUBs, New Members in the Hypoxia Signaling clUb
Schober, A. S., & Berra, E. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00053 · Cited by 21
Succinat-Dehydrogenase(SDH)-defizientes Nierenzellkarzinom
Agaimy, A. (2016) · Der Pathologe · doi:10.1007/s00292-016-0158-8 · Cited by 17
Metformin enhances antitumor action of sodium dichloroacetate against glioma C6
Kolesnik, D. L., Pyaskovskaya, O. N., Yurchenko, O. V., & Solyanik, G. I. (2019) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-41-no-2.13064 · Cited by 15
The Purine Nucleotide Cycle Activity in Renal Cortex and Medulla
Stępiński, J., Bizon, D., Piec, G., & Angielski, S. (1989) · American Journal of Kidney Diseases · doi:10.1016/s0272-6386(89)80209-4 · Cited by 9
Metformin enhances cytotoxic action of dichloroacetate against Lewis lung carcinoma cells in vitro
Kolesnik, D. L., Pyaskovskaya, O. N., Gorbach, O. I., & Solyanik, G. I. (2020) · Experimental Oncology · doi:10.32471/exp-oncology.2312-8852.vol-42-no-1.14318 · Cited by 4
Cited by
Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches
Liu, F., Chen, J., Li, K., Li, H., Zhu, Y., Zhai, Y., Lu, B., Fan, Y., Liu, Z., Chen, X., et al. (2024) · Molecular Cancer · doi:10.1186/s12943-024-02046-3 · Cited by 326
Oxidative Stress and Beta Amyloid in Alzheimer’s Disease. Which Comes First: The Chicken or the Egg?
Tamagno, E., Guglielmotto, M., Vasciaveo, V., & Tabaton, M. (2021) · Antioxidants · doi:10.3390/antiox10091479 · Cited by 264
Metadata
- Authors
- Paredes, F., Williams, H. C., & San Martin, A.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2021-04
- Volume
- 502
- Pages
- 133-142
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W3118914860
- Cited by
- 259
- References
- 140
- FWCI
- 10.97
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.